Clinical Trial Update: Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating a fixed-dose combination of naratriptan and naproxen for acute treatment of migraine has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Headache
• Migraine

Drugs mentioned

• Naproxen (Naproxen)
• Naratriptan (Naratriptan)

Snippet

Sponsor: Ache Laboratorios Farmaceuticos S.A. | Conditions: Migraine, Headache | Phase 3 | Status: WITHDRAWN